SCHEMBL7080643

SCHEMBL7080643

CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1ccccc1Oc1ccoc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.43
PTK2 Q05397 1/20 0.41
HSD17B10 Q99714 2/20 0.41
MTNR1B P49286 2/20 0.40
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
MRGPRX1 Q96LB2 3/20 0.39
L3MBTL1 Q9Y468 4/20 0.38
NPSR1 Q6W5P4 2/20 0.38
POLB P06746 1/20 0.38
ATM Q13315 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
F2R P25116 1/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.37
ELANE P08246 1/20 0.37
PRTN3 P24158 1/20 0.37
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7081568 0.86 PTK2 (0.41) PTK2HSD17B10MAPTGAAMAPK1
SCHEMBL7076729 0.83 MTNR1B (0.45) RAB9AHSD17B10MTNR1BMAPTL3MBTL1
SCHEMBL7083369 0.83 RAB9A (0.43) RAB9AHSD17B10MTNR1BMAPTGAA
SCHEMBL7080256 0.82 HSD17B10 (0.50) RAB9AHSD17B10MTNR1BMAPTGAA
SCHEMBL7083339 0.77 CAPN1 (0.46) RAB9AMAPTGAAMAPK1MEN1
SCHEMBL7077440 0.75 MAPT (0.41) HSD17B10MAPTGAAMAPK1L3MBTL1
SCHEMBL7080331 0.74 SGMS2 (0.52) MEN1KMT2A
SCHEMBL7076725 0.74 MTNR1B (0.48) RAB9AMTNR1BNPSR1MEN1KMT2A
SCHEMBL7744231 0.73 CASP1 (0.51) MTNR1BL3MBTL1NPSR1POLBATM
SCHEMBL7080300 0.72 ALDH1A1 (0.48) RAB9AMTNR1BMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN RAB9A 3579/4885PTK2 1999/4885HSD17B10 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.